Anixa Biosciences, the Company Trying to Stop Cancer Before It Starts
Meditech Wire
CEO Dr. Amit Kumar Discusses Anixa Biosciences’ Innovative Approach to Help T-Cells Address Solid Tumors
WTR Healthcare Happenings
Promising breast cancer vaccine could be available by 2030, researchers say
WPTV West Palm Beach
There's a Breast Cancer Vaccine in the Works — Here's What to Know
Popsugar
The end of breast cancer? Bay Area company says its potential vaccine could block tumors
San Franscisco Business Times
Is There Really About to Be a Breast Cancer Vaccine?
Flow Space
Latest News & Events
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
Read More...Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
Read More...Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Read More...